The medical devices market is segmented into clinical pathology or in vitro diagnostics (IVD reagents and equipment) and radiology or in vivo (diagnostic imaging) testing devices. The IVD market, by market segments, is further segmented into clinical chemistry, molecular diagnostics, immunoassay, microbiology, coagulation analysis, hematology, urinalysis, and other types of testing technologies; and by therapy areas such as cancer, infectious diseases, diabetes, cardiology, nephrology, virology, immunology, and others.
The IVD market in India is expected to grow multifold during the forecast period 2019–2025, mainly because of rising healthcare expenditures, possible upcoming medical devices-related policies to support domestic manufacturing, expanding healthcare access in tier-II and tier-III cities, increasing investments from healthcare providers, and diagnostic labs at new locations outside saturated markets.
Apart from the factors mentioned above, the Indian IVD market is immensely driven by the increase in the number of chronic and lifestyle-related disorders, increasing cancer incidences, growing awareness on the importance of early diagnosis and prevention, improving access to healthcare facilities and diagnostic set-ups.
The report “Indian In Vitro Diagnostics Market” provides an in-depth understanding of the current (2018) market size, structure, and detailed information by sub-segments (reagents and equipment), market segments, therapeutic areas, end-users, and by regions (North, South, East, and West). The report also provides a comprehensive competition landscape of IVD in India along with a comprehensive profile of major companies.
According to Infoholic Research, the Indian In Vitro Diagnostics market is expected to grow at a CAGR between 12%** and 15%** during the forecast period 2019–2025. This report provides a detailed study and revenue opportunity of IVD reagents and equipment across various segments such as market segments, therapy areas, and applications. The report also covers sub-market segments such as within immunoassay equipment market – chemiluminescence (CLI) analyzers, radioimmunoassay (RIA) analyzers, immunofluorescence (IFA) analyzers, and enzyme-linked immunosorbent assay (ELISA) instruments along with the coverage of market segment breakdown by fully and semi-automated systems.
This report also provides a comprehensive competitive landscape by market segments and therapeutic segments along with a detailed profile of key suppliers such as Abbott, Siemens Healthineers, Beckman Coulter (Danher Corporation), Becton Dickinson, BioMerieux, and Sysmex.
**Initial estimated growth range and subject to change in the report.